logo

Bajaj Finserv Healthcare Reg IDCW-R

0

0.00(0%)
NAV as of . Log in to view Live prices
Open Free Demat Account

By signing up I certify terms, conditions & privacy policy

Scheme Information

Logo

Bajaj Finserv Healthcare Reg IDCW-R

as of 02 May 2026, 15:26 PM

Scheme Asset Size₹300.45 Cr
Expense Ratio2.39%
Cash Holding4.91808%
Fund TypeOpen-End
PlanDividend
BenchmarkBSE Healthcare TR INR
Launch Date2024-12-27
Exit LoadExit load of 1.00% for investments if redeemed within 3 Months

SIP Calculator

12%
₹5,000
₹500₹10,00,000
10 Years
1 Year40 Years
Invested Amount
Estimated Return

Invested Amount

₹6,00,000

Est. Return

₹5,61,695

Total Value

₹11,61,695

Invested Amount
Estimated Return
Invest Now

Scheme Ratings

-

rated by Value Research

Scheme Riskometer

Your principal will be at Very High Risk

Investment Returns

Absolute Returns

CAGR

In the last 1 months 6.52%
In the last 3 months 7.59%
In the last 6 months -0.37%
In the last 1 Years 5.69%
In the last 3 Years 0.00%
In the last 5 Years 0.00%

Company Holdings

Company Name
Sector
Instrument
Assets
Sun Pharmaceuticals Industries LtdHealthcareE9.41%
Divi's Laboratories LtdHealthcareE8.95%
Apollo Hospitals Enterprise LtdHealthcareE6.75%
Aurobindo Pharma LtdHealthcareE6.63%
Piramal Pharma LtdHealthcareE5.69%
Torrent Pharmaceuticals LtdHealthcareE5.57%
Emcure Pharmaceuticals LtdHealthcareE4.35%
Max Healthcare Institute Ltd Ordinary SharesHealthcareE4.06%
Rubicon Research LtdHealthcareE3.84%
Neuland Laboratories LtdHealthcareE3.42%
Fortis Healthcare LtdHealthcareE3.18%
Ipca Laboratories LtdHealthcareE2.69%
Zydus Wellness LtdConsumer DefensiveE2.46%
Navin Fluorine International LtdBasic MaterialsE2.05%
Sanofi Consumer Healthcare India LtdHealthcareE1.98%
Glenmark Pharmaceuticals LtdHealthcareE1.97%
GlaxoSmithKline Pharmaceuticals LtdHealthcareE1.81%
Vijaya Diagnostic Centre LtdHealthcareE1.77%
Shaily Engineering Plastics LtdBasic MaterialsE1.72%
Bajaj Finserv Money Market Dir Gr-FO1.71%
Laurus Labs LtdHealthcareE1.65%
Godrej Consumer Products LtdConsumer DefensiveE1.64%
Lupin LtdHealthcareE1.56%
Dr. Lal PathLabs LtdHealthcareE1.54%
Abbott India LtdHealthcareE1.50%
Medplus Health Services LtdHealthcareE1.44%
Biocon LtdHealthcareE1.38%
Eris Lifesciences Ltd Registered ShsHealthcareE1.08%
Krishna Institute of Medical Sciences LtdHealthcareE1.03%
Medi Assist Healthcare Services LtdHealthcareE0.99%
Jubilant Pharmova LtdHealthcareE0.95%
Emami LtdConsumer DefensiveE0.85%
AstraZeneca Pharma India LtdHealthcareE0.84%
Net Receivables / (Payables)-C3.50%
Clearing Corporation Of India Ltd-CR0.02%
Hindustan Unilever Ltd-E-
Tata Consumer Products Ltd-E-
Cipla Ltd-E-
Alembic Pharmaceuticals Ltd-E-
Kwality Walls India Ltd-E-

Sector Holding Analysis

Equity / Debt / Cash Split

Loading chart…

Equity

94.78%

Debt

0.3%

Cash

4.92%

Others

0.01%

Equity sector allocation

Loading chart…

Basic Materials

3.77%

Consumer Defensive

4.95%

Healthcare

86.06%

Others

5.22%

Fund House Contact Details

Websitehttps://www.bajajamc.com/
Phone+91 20 67672500
Logo
Bajaj Finserv Asset Management Limited

Asset Management Company

About Bajaj Finserv Healthcare Reg IDCW-R

Investment Objective of the Scheme

The objective of the Scheme is to generate long term capital appreciation by predominantly investing in equity and equity related securities of pharma, healthcare and allied companies.

Key Features of The Fund

5-year return

-

Fund Manager

Nimesh Chandan

Risk Profile

Very High Risk

Expense Ratio

2.39%

Fund Size

₹300.45 Cr

FAQ's

Desktop BannerMobile Banner
Invest Anytime, Anywhere
Play StoreApp Store
Open Free Demat Account Online

By signing up I certify terms, conditions & privacy policy